![Bernard Mach](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bernard Mach
Gründer bei MaxiVAX SA
Ursprung des Netzwerks ersten Grades von Bernard Mach
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Serono SA
![]() Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland.
20
| Extinct | Pharmaceuticals: Major | 20 |
MaxiVAX SA
![]() MaxiVAX SA Miscellaneous Commercial ServicesCommercial Services MaxiVAX SA is a Swiss clinical stage biotechnology company. The private company is based in Geneva, Switzerland. The company was founded by Bernard Mach.
4
| Private Company | Miscellaneous Commercial Services | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Bernard Mach
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Bausch Health Americas, Inc.
![]() Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
PricewaterhouseCoopers LLP
![]() PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Merck Serono SA
![]() Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Director of Finance/CFO President Corporate Officer/Principal Public Communications Contact Corporate Officer/Principal Sales & Marketing | |
University of Cambridge | College/University | Graduate Degree Doctorate Degree | |
University of Zurich | College/University | Doctorate Degree Doctorate Degree | |
University of Geneva | College/University | Graduate Degree Doctorate Degree | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Graduate Degree | |
Metriopharm AG
![]() Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Director of Finance/CFO | |
ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Director/Board Member | |
Combe, Inc.
![]() Combe, Inc. Household/Personal CareConsumer Non-Durables Combe, Inc. manufactures personal care products. Its products include hair care, feminine care and denture products. The company was founded in 1949 by Ivan D. Combe and is headquartered in White Plains, NY. | Household/Personal Care | General Counsel | |
Bristol-Myers Squibb SARL
![]() Bristol-Myers Squibb SARL Medical DistributorsDistribution Services Bristol-Myers Squibb SARL engages in the research, development, manufacture, and distribution of pharmaceutical products. Its therapeutic areas include immunoscience, immune-oncology, and cardiology. The company is headquartered in Rueil-Malmaison, France. | Medical Distributors | Corporate Officer/Principal | |
AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Index Ventures SA
![]() Index Ventures SA Investment ManagersFinance Index Ventures SA (Index Ventures) is a venture capital firm founded in 1996 by Neil Alexander Rimer, Gluseppe Zocco and Gerald Rimer. The firm is headquartered in Geneva, Switzerland. | Investment Managers | Private Equity Analyst | |
Imperial College London | College/University | Doctorate Degree | |
GlaxoSmithKline AG
![]() GlaxoSmithKline AG Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline AG is a company based in Munchenbuchsee, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MedXCell SA
![]() MedXCell SA BiotechnologyHealth Technology MedXCell SA is a European cell therapy venture builder that focuses on identifying scientific breakthroughs and transforming them into clinical assets. The private company is based in Montreux, Switzerland. The Swiss company has a strong industrial mindset and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development, and funding capabilities. MedXCell scouts for promising ideas within its European academic network of partners, selects the most commercially-viable ideas, and co-develops them with academic institutions until the proof-of-principle stage. The company creates pipeline companies based on those ideas that can be funded independently and monetizes those that can be sold or out-licensed as early-stage assets. MedXCell was founded in 2016 by Laurent Zbinden, who has been the CEO since then. | Biotechnology | Director/Board Member | |
NextPharma Technologies Ltd.
![]() NextPharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology NextPharma Technologies, In. develops, manufactures, packages, and distributes pharmaceutical products and formulations. The firm focuses on lyophilization, sterile fill finish and pellet technologies, and in product manufacturing including cyotoxics, hormones, penicillins, cephalosporins, and controlled drugs. The company was established on October 27, 2000 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
University of Fribourg | College/University | Undergraduate Degree | |
Inotrem SA
![]() Inotrem SA BiotechnologyHealth Technology Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France. | Biotechnology | Chief Executive Officer | |
NextPharma Technologies Holding Ltd.
![]() NextPharma Technologies Holding Ltd. Pharmaceuticals: MajorHealth Technology NextPharma Technologies Holding Ltd. operates as a pharmaceutical contract development and manufacturing firm. It specializes in modified release technologies and in product manufacturing including hormones, penicillin, and cephalosporin. The company was founded on January 2, 2003 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
NAVIOS MARITIME HOLDINGS INC. | Marine Shipping | Director/Board Member | |
Université de Bordeaux | College/University | Doctorate Degree | |
Napp Pharmaceutical Holdings Ltd.
![]() Napp Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Mundipharma, Inc.
![]() Mundipharma, Inc. Pharmaceuticals: MajorHealth Technology Mundipharma, Inc. manufactures and markets pharmaceutical products. The company is located in Albany, NY. | Pharmaceuticals: Major | Director/Board Member | |
Sofinnova Partners SAS
![]() Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Private Equity Investor | |
Vifor Pharma Management AG
![]() Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Chairman | |
Centro de Estudios Financieros | College/University | Masters Business Admin | |
Sofinnova Crossover Fund
![]() Sofinnova Crossover Fund Financial ConglomeratesFinance Sofinnova Crossover Fund provides investment services. | Financial Conglomerates | Corporate Officer/Principal | |
Commave Therapeutics SA
![]() Commave Therapeutics SA Pharmaceuticals: MajorHealth Technology Commave Therapeutics SA is a Swiss pharmaceutical manufacturing company. The private company is based in Geneva, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Brown University | College/University | Undergraduate Degree | |
BIOTON S.A. | Pharmaceuticals: Major | Director/Board Member | |
University of Milan | College/University | Doctorate Degree | |
Auregen Biotherapeutics SA
![]() Auregen Biotherapeutics SA Packaged SoftwareTechnology Services Auregen Biotherapeutics SA develops three dimensional (3D) bioprinting technology for patients with rare disorders. The company is headquartered in Geneva, Switzerland. | Packaged Software | Director/Board Member | |
STALLERGENES GREER | Pharmaceuticals: Major | Director/Board Member | |
Stallergenes Canada, Inc. | Director/Board Member | ||
Skylark Bio, Inc.
![]() Skylark Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Skylark Bio, Inc. operates as a biotechnology company. The company is based in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
NormOxys, Inc.
![]() NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Pharmaceuticals: Major | Director/Board Member | |
OncoEthix SA
![]() OncoEthix SA Pharmaceuticals: MajorHealth Technology OncoEthix SA operates as a clinical stage biotechnology company which develops cancer drugs. Its products include OTX008, OTX015, and OTX009. The company was founded by Esteban Cvitkovic, Jeanne Kay Noel, Yves Paternot, and Patrice Herait in March 2007 and is headquartered in Luzern, Switzerland. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
Schweiz | 18 |
Vereinigte Staaten | 10 |
Vereinigtes Königreich | 10 |
Frankreich | 6 |
China | 2 |
Sektoral
Health Technology | 26 |
Consumer Services | 11 |
Finance | 5 |
Commercial Services | 3 |
Consumer Non-Durables | 2 |
Operativ
Director/Board Member | 89 |
Corporate Officer/Principal | 48 |
Chairman | 19 |
Independent Dir/Board Member | 14 |
Director of Finance/CFO | 13 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Bernard Mach
- Unternehmensverbindungen